PM ON COVID-19 TREATMENT APPROVAL
입력 2021.01.14 (15:04)
수정 2021.01.14 (16:45)
읽어주기 기능은 크롬기반의
브라우저에서만 사용하실 수 있습니다.
[Anchor Lead]
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
■ 제보하기
▷ 카카오톡 : 'KBS제보' 검색, 채널 추가
▷ 전화 : 02-781-1234, 4444
▷ 이메일 : kbs1234@kbs.co.kr
▷ 유튜브, 네이버, 카카오에서도 KBS뉴스를 구독해주세요!
- PM ON COVID-19 TREATMENT APPROVAL
-
- 입력 2021-01-14 15:04:04
- 수정2021-01-14 16:45:26
[Anchor Lead]
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
이 기사가 좋으셨다면
-
좋아요
0
-
응원해요
0
-
후속 원해요
0
오늘의 핫 클릭
실시간 뜨거운 관심을 받고 있는 뉴스
헤드라인
많이 본 뉴스
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
이 기사에 대한 의견을 남겨주세요.